This is the authors' abstract. We don't add key points for this paper.
China's healthcare reform faces significant hurdles like inefficient medical insurance fund utilization, imbalanced medical resource distribution, and limited innovation in biopharmaceuticals, necessitating smarter technological interventions. This article assesses the impact of smart healthcare in China's reform agenda. Innovative payment methods like Diagnosis-Related Group (DRG) and Disease Group Payment (DIP), bolstered by big data, have reduced patient burdens. Digitization in medical services has streamlined processes, improved patient experiences, and tackled regional resource disparities. Technologies such as artificial intelligence have accelerated drug development, boosting efficiency and precision. Yet, smart healthcare encounters challenges. To address these, the article suggests enhancing top-level design for technology standards, ensuring secure data sharing, advancing health technology assessments, and nurturing skilled personnel in smart technology.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: